Alzheimer's is a devastating disease impacting millions of families and our nation's economy. The only way to change this is through research.

That is why the Alzheimer's Association, working with and through the Alzheimer's Impact Movement (AIM), is leading the way to increase research funding at federal and state levels.

We have propelled the federal government to rise to this challenge, resulting in a more than seven-fold increase in federal Alzheimer's and dementia research funding since 2011. Today, Alzheimer's and dementia research funding at the National Institutes of Health (NIH) is as much as $3.8 billion annually.

As a result of this unprecedented funding, scientists are able to work at a more rapid pace to advance basic disease knowledge, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug targeting, and develop potential treatments.